Movetis Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 29

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $528M

Movetis General Information

Description

Developer of drugs for the treatment of diseases in the gastrointestinal (GI) area. The company's products address GI disorders, such as severe chronic constipation, ascites, paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. Its lead product, Resolor, is used for the symptomatic treatment of chronic constipation in women.

Contact Information

Website
www.movetis.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • Veedijk 58 1004
  • 2300 Turnhout
  • Belgium
+32 014 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Movetis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Nov-2010 $528M 00000 00000 Completed Generating Revenue
2. IPO 03-Dec-2009 00000 00000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 08-Jan-2007 $64.4M $64.4M Completed Product Development
To view Movetis’s complete valuation and funding history, request access »

Movetis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Movetis Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BIP Capital Partners PE/Buyout Minority 000 0000 000000 0
EQT Life Sciences Venture Capital Minority 000 0000 000000 0
Gimv PE/Buyout Minority 000 0000 000000 0
KBC Group Corporation Minority 000 0000 000000 0
Quest For Growth Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Movetis FAQs

  • When was Movetis founded?

    Movetis was founded in 2006.

  • Who is the founder of Movetis?

    Dirk Reyn and Staf Van Reet Ph.D are the founders of Movetis.

  • Where is Movetis headquartered?

    Movetis is headquartered in Turnhout, Belgium.

  • What is the size of Movetis?

    Movetis has 29 total employees.

  • What industry is Movetis in?

    Movetis’s primary industry is Drug Discovery.

  • Is Movetis a private or public company?

    Movetis is a Private company.

  • What is the current valuation of Movetis?

    The current valuation of Movetis is 00000.

  • What is Movetis’s current revenue?

    The current revenue for Movetis is 00000.

  • How much funding has Movetis raised over time?

    Movetis has raised $191M.

  • Who are Movetis’s investors?

    BIP Capital Partners, EQT Life Sciences, Gimv, KBC Group, and Quest For Growth are 5 of 7 investors who have invested in Movetis.

  • When was Movetis acquired?

    Movetis was acquired on 09-Nov-2010.

  • Who acquired Movetis?

    Movetis was acquired by Shire.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »